Skip to main content
Erschienen in: Osteoporosis International 11/2016

08.06.2016 | Original Article

Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis

verfasst von: A. Balasubramanian, S. W. Wade, R. A. Adler, C. J. F. Lin, M. Maricic, C. D. O’Malley, K. Saag, J. R. Curtis

Erschienen in: Osteoporosis International | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Summary

Retrospective claims analysis indicated that high levels of daily and cumulative doses of systemic glucocorticoids were associated with elevated fracture risk in a large cohort of new RA patients under age 65. Heightened risk began to decline within months of discontinuation. Findings were similar among patients age <50 years.

Introduction

We evaluated the impact of systemic glucocorticoid exposure on fracture risk among relatively young patients with new-onset rheumatoid arthritis (RA).

Methods

Using administrative data, we identified 42,127 RA patients diagnosed January 1, 2005–December 31, 2012, age 18–64 years, with benefits coverage for ≥12 months before RA diagnosis. Follow-up extended to clinical fracture, cancer diagnosis, or December 31, 2012. Glucocorticoid users were new to therapy. Fracture incidence rates (IR) were stratified by glucocorticoid exposure expressed as prednisone equivalent doses. Cox’s proportional hazards models estimated fracture risk adjusted for demographics and baseline clinical characteristics to assess dose-response relationships with current (daily) and prior (cumulative) dose, and by time since discontinuation.

Results

Most patients (85 %) had glucocorticoid exposure. Exposed and unexposed patients were demographically similar (74 % female; mean age 49.7 and 48.8 years); 1 % had prior fracture. Fracture IRs (95 % confidence intervals) were 5 to 9 per 1000 person-years at doses <15 mg/day, 16.0 (11.0, 22.6) at doses ≥15 mg/day, and 13.4 (10.7, 16.7) at cumulative doses ≥5400 mg. Adjusted fracture risk was approximately 2-fold higher at highest dose levels compared with 0 mg/day current daily dose and <675 mg cumulative dose, respectively. Fracture risk was 29 % lower at 60–182 days post-discontinuation compared with ongoing use and was similar to unexposed patients by 12 months. Findings were similar among patients age <50 years.

Conclusions

Among younger, new-onset RA patients, fracture risk was significantly elevated at high levels of daily and cumulative dose, and was similar to unexposed patients by 12 months post-discontinuation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat van Everdingen AA, Jacobs JW (2002) Siewertsz Van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136(1):1–12CrossRefPubMed van Everdingen AA, Jacobs JW (2002) Siewertsz Van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136(1):1–12CrossRefPubMed
4.
Zurück zum Zitat van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39(12):1383–9CrossRefPubMed van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39(12):1383–9CrossRefPubMed
5.
Zurück zum Zitat Hoes JN, Jacobs JW, Hulsmans HM, De Nijs RN, Lems WF, Bruyn GA et al (2010) High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial. Clin Exp Rheumatol 28(3):354–9PubMed Hoes JN, Jacobs JW, Hulsmans HM, De Nijs RN, Lems WF, Bruyn GA et al (2010) High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial. Clin Exp Rheumatol 28(3):354–9PubMed
7.
Zurück zum Zitat Lukert BP, Raisz LG (1994) Glucocorticoid-induced osteoporosis. Rheum Dis Clin N Am 20(3):629–50 Lukert BP, Raisz LG (1994) Glucocorticoid-induced osteoporosis. Rheum Dis Clin N Am 20(3):629–50
8.
Zurück zum Zitat Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S et al (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2):253–9. doi:10.1016/j.bone.2006.02.005 CrossRefPubMed Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S et al (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2):253–9. doi:10.​1016/​j.​bone.​2006.​02.​005 CrossRefPubMed
9.
Zurück zum Zitat Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–9. doi:10.1002/art.11283 CrossRefPubMed Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–9. doi:10.​1002/​art.​11283 CrossRefPubMed
10.
Zurück zum Zitat De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56(1):208–14. doi:10.1002/art.22294 CrossRefPubMed De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56(1):208–14. doi:10.​1002/​art.​22294 CrossRefPubMed
11.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C et al (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 15(1):20–6. doi:10.1007/s00198-003-1463-7 CrossRef Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C et al (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 15(1):20–6. doi:10.​1007/​s00198-003-1463-7 CrossRef
12.
13.
Zurück zum Zitat Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 15(4):323–8. doi:10.1007/s00198-003-1548-3 CrossRef Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 15(4):323–8. doi:10.​1007/​s00198-003-1548-3 CrossRef
14.
Zurück zum Zitat Majumdar SR, Morin SN, Lix LM, Leslie WD (2013) Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 24(9):2493–8. doi:10.1007/s00198-013-2352-3 CrossRef Majumdar SR, Morin SN, Lix LM, Leslie WD (2013) Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 24(9):2493–8. doi:10.​1007/​s00198-013-2352-3 CrossRef
15.
Zurück zum Zitat van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–12. doi:10.1002/art.22117 CrossRefPubMed van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–12. doi:10.​1002/​art.​22117 CrossRefPubMed
16.
Zurück zum Zitat McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM et al (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):704–9. doi:10.1164/ajrccm.157.3.9703080 CrossRefPubMed McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM et al (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):704–9. doi:10.​1164/​ajrccm.​157.​3.​9703080 CrossRefPubMed
17.
Zurück zum Zitat Walsh LJ, Wong CA, Oborne J, Cooper S, Lewis SA, Pringle M et al (2001) Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56(4):279–84CrossRefPubMedPubMedCentral Walsh LJ, Wong CA, Oborne J, Cooper S, Lewis SA, Pringle M et al (2001) Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56(4):279–84CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH (1985) Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 28(4):361–8CrossRefPubMed Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH (1985) Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 28(4):361–8CrossRefPubMed
19.
Zurück zum Zitat Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48(7):535–8CrossRefPubMedPubMedCentral Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48(7):535–8CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24(8):1489–94PubMed Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24(8):1489–94PubMed
22.
23.
Zurück zum Zitat Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62(11):1515–26. doi:10.1002/acr.20295 CrossRef Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62(11):1515–26. doi:10.​1002/​acr.​20295 CrossRef
25.
Zurück zum Zitat Ray WA, Griffin MR, Fought RL, Adams ML (1992) Identification of fractures from computerized Medicare files. J Clin Epidemiol 45(7):703–14CrossRefPubMed Ray WA, Griffin MR, Fought RL, Adams ML (1992) Identification of fractures from computerized Medicare files. J Clin Epidemiol 45(7):703–14CrossRefPubMed
26.
Zurück zum Zitat Baron JA, Lu-Yao G, Barrett J, McLerran D, Fisher ES (1994) Internal validation of Medicare claims data. Epidemiology 5(5):541–4PubMed Baron JA, Lu-Yao G, Barrett J, McLerran D, Fisher ES (1994) Internal validation of Medicare claims data. Epidemiology 5(5):541–4PubMed
27.
Zurück zum Zitat Faraone SV (2008) Interpreting estimates of treatment effects: implications for managed care. P & T: a Peer-Rev J Formul Manag 33(12):700–11 Faraone SV (2008) Interpreting estimates of treatment effects: implications for managed care. P & T: a Peer-Rev J Formul Manag 33(12):700–11
28.
Zurück zum Zitat Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64(5):625–39. doi:10.1002/acr.21641 CrossRef Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64(5):625–39. doi:10.​1002/​acr.​21641 CrossRef
29.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–9CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–9CrossRefPubMed
30.
Zurück zum Zitat van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 13(10):777–87. doi:10.1007/s001980200108 CrossRef van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 13(10):777–87. doi:10.​1007/​s001980200108 CrossRef
31.
Zurück zum Zitat Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Min Res Off J Am Soc Bone Miner Res 29(3):581–9. doi:10.1002/jbmr.2072 CrossRef Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Min Res Off J Am Soc Bone Miner Res 29(3):581–9. doi:10.​1002/​jbmr.​2072 CrossRef
35.
Zurück zum Zitat Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology. doi:10.1093/rheumatology/keu162 PubMed Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology. doi:10.​1093/​rheumatology/​keu162 PubMed
37.
Zurück zum Zitat Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O et al (2000) A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 27(11):2582–9PubMed Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O et al (2000) A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 27(11):2582–9PubMed
38.
Zurück zum Zitat Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52(8):2485–94. doi:10.1002/art.21194 CrossRefPubMed Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52(8):2485–94. doi:10.​1002/​art.​21194 CrossRefPubMed
39.
Zurück zum Zitat Caplan L, Hines AE, Williams E, Prochazka AV, Saag KG, Cunningham F et al (2011) An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 22(1):305–15. doi:10.1007/s00198-010-1201-x CrossRef Caplan L, Hines AE, Williams E, Prochazka AV, Saag KG, Cunningham F et al (2011) An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis. Osteoporos Int: a J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 22(1):305–15. doi:10.​1007/​s00198-010-1201-x CrossRef
40.
Zurück zum Zitat Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD (2012) Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab 97(4):1236–42. doi:10.1210/jc.2011-2645 CrossRefPubMed Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD (2012) Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab 97(4):1236–42. doi:10.​1210/​jc.​2011-2645 CrossRefPubMed
41.
Zurück zum Zitat McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA et al (2012) Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. Rheumatology 51(9):1662–9. doi:10.1093/rheumatology/kes079 CrossRefPubMed McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA et al (2012) Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. Rheumatology 51(9):1662–9. doi:10.​1093/​rheumatology/​kes079 CrossRefPubMed
Metadaten
Titel
Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis
verfasst von
A. Balasubramanian
S. W. Wade
R. A. Adler
C. J. F. Lin
M. Maricic
C. D. O’Malley
K. Saag
J. R. Curtis
Publikationsdatum
08.06.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 11/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3646-z

Weitere Artikel der Ausgabe 11/2016

Osteoporosis International 11/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.